2009
DOI: 10.1128/aem.00842-09
|View full text |Cite
|
Sign up to set email alerts
|

Glycoprofiling Bifidobacterial Consumption of Galacto-Oligosaccharides by Mass Spectrometry Reveals Strain-Specific, Preferential Consumption of Glycans

Abstract: Galacto-oligosaccharides (GOS) are versatile food ingredients that possess prebiotic properties. However, at present there is a lack of precise analytical methods to demonstrate specific GOS consumption by bifidobacteria. To better understand the role of GOS as prebiotics, purified GOS (pGOS) without disaccharides and monosaccharides was prepared and used in bacterial fermentation experiments. Growth curves showed that all bifidobacteria assayed utilized and grew on pGOS preparations. We used a novel mass spec… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
56
1

Year Published

2010
2010
2020
2020

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 77 publications
(62 citation statements)
references
References 22 publications
5
56
1
Order By: Relevance
“…scGOS (FrieslandCampina Domo) supplemented to the milk formulas CMF1 and CMF2, which triggered these allergic reactions in our patients, is prepared with a b-galactosidase derived from Bacillus circulans and is a well-characterized mixture of more than 50 different oligosaccharides. 15 These oligosaccharides are composed of 1 to 7 galactose units linked to a glucose molecule in proportion of DPs as follows: DP5 or greater, 6.6%; DP4, 10.8%; DP3, 22.1%; DP2, 37.4%; and DP1, 22.5%. 9 The b-glycosidic linkage between the monomer units is mainly the linear linkage 1/4 Gal, although other b-glycosidic linkages, among which are found branched linkages, can also include the following: 1/6 Gal, 1 /2 Glc, 1/3 Glc, 1/4 Glc, 1/6 Glc, 1/2 Gal, and 1/3 Gal.…”
Section: Discussionmentioning
confidence: 99%
“…scGOS (FrieslandCampina Domo) supplemented to the milk formulas CMF1 and CMF2, which triggered these allergic reactions in our patients, is prepared with a b-galactosidase derived from Bacillus circulans and is a well-characterized mixture of more than 50 different oligosaccharides. 15 These oligosaccharides are composed of 1 to 7 galactose units linked to a glucose molecule in proportion of DPs as follows: DP5 or greater, 6.6%; DP4, 10.8%; DP3, 22.1%; DP2, 37.4%; and DP1, 22.5%. 9 The b-glycosidic linkage between the monomer units is mainly the linear linkage 1/4 Gal, although other b-glycosidic linkages, among which are found branched linkages, can also include the following: 1/6 Gal, 1 /2 Glc, 1/3 Glc, 1/4 Glc, 1/6 Glc, 1/2 Gal, and 1/3 Gal.…”
Section: Discussionmentioning
confidence: 99%
“…At the same time, it is noteworthy that B. breve and B. longum utilized the small DP4 fraction of GOS-P in addition to the major DP3 fraction. Barboza et al used a novel mass spectrometry approach to profile the consumption of GOS by four bifidobacteria belonging to four different species, 34) reporting that infant-borne isolates were able to consume GOS species with a wide range of DPs, whereas adult-borne isolates exhibited more differential consumption of GOS species with selected DPs. It is conceivable that some of the infant-borne bifidobacteria, such as B. breve and B. bifidum, are more adapted to GOS with higher DPs, whereas the typical adult-borne bifidobacteria such as B. adolescentis are specialist DP3 GOS users.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, the intracellular GH42 ␤-galactosidase Bga42A, which is distant from the HMO cluster, is highly specific for LNT and functions as the sole ␤-galactosidase acting on type I HMOs. In the HMO degradation system of this strain, it was suggested that low molecular weight HMOs (degree of polymerization ranging from 3 to 8) are directly imported into the cells by transporters and subsequently cleaved by intracellular GHs (70). This analysis as well as recent research on commensal bacteria is unveiling the different HMO consumption modes of bifidobacterial strains.…”
mentioning
confidence: 98%